$18m raise to radically reset expectations for aging

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

Insurtech Assured Allies raises $18.3m and will apply data and behavioural science to shift the aging trajectory toward healthier longevity.

Assured Allies, company working in evidence-based successful aging innovation, today announced the close of its $18.3m Series A fundraise. New investors Core Innovation Capital and New Era Capital Partners co-led the round, with participation from Wilton Re, a leading provider of in force and reinsurance solutions. Existing investors LionBird Ventures and Harel Insurance also participated.

Longevity.Technology: Insurtech company Assured Allies has a platform of technology and services that can, it claims, predict and shift the aging trajectory, reduce the risk of age-related decline and help people get the most out of life. It hopes to leverage its platform to offer the insurance industry new models for deeper, more successful relationships with Policyholders.

As the global population ages, people are heading into their later years with higher expectations for quality of life, but without a plan to maintain their wellness. Medical research shows that there are powerful and effective ways to maintain wellness and avoid the rapid decline commonly associated with aging. With biotech investment and by applying population health management techniques and predictive analytics, it should now be possible to pinpoint what’s needed to increase a person’s odds of successful aging at any given time.

“We learned from direct experience caring for our loved ones that the aging process can introduce a host of worries – from physical health to financial security and emotional wellbeing,” said co-founder and CEO Roee Nahir. “We created Assured Allies to address those worries proactively, before they became a problem. In the last three years we have made big strides toward a future in which people are empowered to age on their own terms. And the best is yet to come.”

Assured Allies

The Series A funding will allow Assured Allies to accelerate delivery of its Age Assured programme and continue to develop new successful aging innovations, based on the company’s patent-pending technology for predicting the aging trajectory and its proprietary aging score. Specifically, the company will be introducing an entirely new category of offerings for successful aging that combine wellness with financial products. The breakthrough solutions will help people get the most out of their retirement and could be game-changing for the insurance industry.

“We know so much about how to prevent age-related decline and how to dramatically increase the chances of a longer healthspan – so that we can enjoy a high quality of life into old age,” said Assured Allies co-founder and Chief Product Officer Dr Afik Gal. “We now also have the technological capacity to apply that knowledge in a way that not only benefits individuals, but that is good for business as well.”

“Addressing successful aging is more than a business imperative. It’s a commitment to creating a better society,” said Kat Utecht, Managing Partner, at Core Innovation Capital. “Assured Allies is uniquely positioned to bring innovative, tech-driven approaches to market, with the perspective to design solutions that provide value to both consumers and financial partners focused on the retirement years.”

“We believe there will be an economic return as well as a social return on investing in a future in which people can age successfully. Moreover, we were compelled by the progress Assured Allies has made developing an algorithmic approach to predicting the course of aging,” said Ran Simha, Managing Partner of New Era Capital, the Tel Aviv and Boston-based VC firm. “We founded our firm based on the belief that technology has the power to create a better future. Assured Allies will be instrumental in bringing that vision to reality.”

Assured Allies has dual headquarters outside of Boston and Tel Aviv; the company is part of the thriving Boston “Longevity Hub” and is contributing to the latest developments in predictive analytics, machine learning and AI in both Boston and Tel Aviv.

We’ll shortly be speaking with Dr Gal on shifting the aging trajectory and increasing the chances of successful aging – stay tuned!

Ovarian Longevity webinar

We are currently preparing our market intelligence report on Aging in place; pre-order your copy HERE or check out our other reports HERE.

Images courtesy of EmVision  and Assured Allies
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo Technology Capital Group led the...

Unlocking ovarian aging could prolong fertility and delay menopause

Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Targeting cognitive decline with medical food

Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’. DISCLOSURE: Longevity.Technology (a brand of First...
Nutriop